DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Burns D002056 34 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Carcinoma D002277 18 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Dementia D003704 2 associated lipids
Heart Failure D006333 36 associated lipids
Coronary Disease D003327 70 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Brain Neoplasms D001932 15 associated lipids
Hypothyroidism D007037 32 associated lipids
Vision Disorders D014786 10 associated lipids
Melanoma D008545 69 associated lipids
Pain, Postoperative D010149 13 associated lipids
Asthma D001249 52 associated lipids
Kidney Diseases D007674 29 associated lipids
Weight Gain D015430 101 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Bone Diseases, Metabolic D001851 9 associated lipids
Obesity D009765 29 associated lipids
Thrombosis D013927 49 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Peritonitis D010538 38 associated lipids
Proteinuria D011507 30 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Refsum Disease D012035 19 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arteriosclerosis D001161 86 associated lipids
Leukemia D007938 74 associated lipids
Magnesium Deficiency D008275 9 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Colorectal Neoplasms D015179 10 associated lipids
Optic Nerve Diseases D009901 6 associated lipids
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Lipid Metabolism, Inborn Errors D008052 26 associated lipids
Glomerulonephritis D005921 35 associated lipids
Sepsis D018805 11 associated lipids
Acquired Immunodeficiency Syndrome D000163 12 associated lipids
Psoriasis D011565 47 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Brain Infarction D020520 17 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hyperlipoproteinemia Type IV D006953 6 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Brain Ischemia D002545 89 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Peroxisomal Disorders D018901 5 associated lipids
Birth Weight D001724 23 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Periodontitis D010518 22 associated lipids
Dermatitis D003872 30 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Shock D012769 11 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Yi SH et al. A randomized, placebo-controlled, double-blind trial of supplemental docosahexaenoic acid on cognitive processing speed and executive function in females of reproductive age with phenylketonuria: A pilot study. 2011 Prostaglandins Leukot. Essent. Fatty Acids pmid:22000478
Sidhu VK et al. Effects of docosahexaenoic acid on mouse brain synaptic plasma membrane proteome analyzed by mass spectrometry and (16)O/(18)O labeling. 2011 J. Proteome Res. pmid:22003853
Labayen I et al. Associations of birth weight with serum long chain polyunsaturated fatty acids in adolescents; the HELENA study. 2011 Atherosclerosis pmid:21550607
Granot E et al. DHA supplementation during pregnancy and lactation affects infants' cellular but not humoral immune response. 2011 Mediators Inflamm. pmid:21941411
Rahman M et al. Docosahexaenoic acid inhibits UVB-induced activation of NF-κB and expression of COX-2 and NOX-4 in HR-1 hairless mouse skin by blocking MSK1 signaling. 2011 PLoS ONE pmid:22140508
Johnson B Consciousness reinstated using the certainty principle--a better mental health strategy. 2011 Nutr Health pmid:22141192
Westphal C et al. CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease? 2011 Prostaglandins Other Lipid Mediat. pmid:21945326
Wood PL et al. Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease. 2011 Lipids Health Dis pmid:22142382
Decsi T et al. Inverse association between trans isomeric and long-chain polyunsaturated fatty acids in pregnant women and their newborns: data from three European countries. 2011 Ann. Nutr. Metab. pmid:22142767
Kohlboeck G et al. Effect of fatty acid status in cord blood serum on children's behavioral difficulties at 10 y of age: results from the LISAplus Study. 2011 Am. J. Clin. Nutr. pmid:22071708
Park CK et al. Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. 2011 J. Neurosci. pmid:22016541
James S et al. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). 2011 Cochrane Database Syst Rev pmid:22071839
Ulven SM et al. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. 2011 Lipids pmid:21042875
Morin C et al. Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma. 2011 Am. J. Respir. Cell Mol. Biol. pmid:21057106
Gajos G The fish oil story--back to Greenland? 2011 Cardiology pmid:21757896
Ozsoy O et al. The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease. 2011 Neurochem. Int. pmid:21736911
Haraguchi T et al. Fish oil feeding up-regulates the expression of 5-aminolevulinate synthase 2 mRNA in rat brain. 2011 Biosci. Biotechnol. Biochem. pmid:21737922
Johnsen GM et al. Docosahexaenoic acid stimulates tube formation in first trimester trophoblast cells, HTR8/SVneo. 2011 Placenta pmid:21741084
Lespérance F et al. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial. 2011 J Clin Psychiatry pmid:20584525
Keithly JI et al. Thermogenesis, blood metabolites and hormones, and growth of lambs born to ewes supplemented with algae-derived docosahexaenoic acid. 2011 J. Anim. Sci. pmid:21742943
Sun H et al. Omega-3 fatty acids induce apoptosis in human breast cancer cells and mouse mammary tissue through syndecan-1 inhibition of the MEK-Erk pathway. 2011 Carcinogenesis pmid:21771724
Caputo M et al. Selective regulation of UGT1A1 and SREBP-1c mRNA expression by docosahexaenoic, eicosapentaenoic, and arachidonic acids. 2011 J. Cell. Physiol. pmid:20648548
Opreanu M et al. The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models. 2011 Diabetes pmid:21771974
Serebruany VL et al. Early impact of prescription Omega-3 fatty acids on platelet biomarkers in patients with coronary artery disease and hypertriglyceridemia. 2011 Cardiology pmid:21701167
Frisardi V et al. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. 2011 Prog. Lipid Res. pmid:21703303
Walczewska A et al. [The role of docosahexaenoic acid in neuronal function]. 2011 Postepy Hig Med Dosw (Online) pmid:21677356
Davis-Bruno K and Tassinari MS Essential fatty acid supplementation of DHA and ARA and effects on neurodevelopment across animal species: a review of the literature. 2011 Birth Defects Res. B Dev. Reprod. Toxicol. pmid:21678548
Klingler M et al. Fatty acid status determination by cheek cell sampling combined with methanol-based ultrasound extraction of glycerophospholipids. 2011 Lipids pmid:21681560
Friedrichs W et al. Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression. 2011 Nutr Cancer pmid:21667400
Sakayori N et al. Distinctive effects of arachidonic acid and docosahexaenoic acid on neural stem /progenitor cells. 2011 Genes Cells pmid:21668588
Liu SJ et al. Effect of ruminal pulse dose of polyunsaturated fatty acids on ruminal microbial populations and duodenal flow and milk profiles of fatty acids. 2011 J. Dairy Sci. pmid:21605768
Cook DJ and Heyland DK Pharmaconutrition in acute lung injury. 2011 JAMA pmid:21976612
Rice TW et al. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. 2011 JAMA pmid:21976613
Faragó N et al. MicroRNA profile of polyunsaturated fatty acid treated glioma cells reveal apoptosis-specific expression changes. 2011 Lipids Health Dis pmid:21961478
Wu A et al. The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. 2011 J. Neurotrauma pmid:21851229
Weise C et al. Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFκB pathway in human B cells. 2011 J. Nutr. Biochem. pmid:20576420
Lalancette-Hébert M et al. Accumulation of dietary docosahexaenoic acid in the brain attenuates acute immune response and development of postischemic neuronal damage. 2011 Stroke pmid:21852616
Schuchardt JP et al. Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil. 2011 Lipids Health Dis pmid:21854650
Murakami M Lipid mediators in life science. 2011 Exp. Anim. pmid:21325748
Beck G et al. Neuroaxonal dystrophy in calcium-independent phospholipase A2β deficiency results from insufficient remodeling and degeneration of mitochondrial and presynaptic membranes. 2011 J. Neurosci. pmid:21813701
Konrad M et al. The acute effect of ingesting a quercetin-based supplement on exercise-induced inflammation and immune changes in runners. 2011 Int J Sport Nutr Exerc Metab pmid:21813917
Morin C et al. 19,20-EpDPE, a bioactive CYP450 metabolite of DHA monoacyglyceride, decreases Ca²⁺ sensitivity in human pulmonary arteries. 2011 Am. J. Physiol. Heart Circ. Physiol. pmid:21821782
Kuipers RS et al. Postpartum changes in maternal and infant erythrocyte fatty acids are likely to be driven by restoring insulin sensitivity and DHA status. 2011 Med. Hypotheses pmid:21388747
Boucher O et al. Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age. 2011 Am. J. Clin. Nutr. pmid:21389181
Grant GE et al. Enhanced formation of 5-oxo-6,8,11,14-eicosatetraenoic acid by cancer cells in response to oxidative stress, docosahexaenoic acid and neutrophil-derived 5-hydroxy-6,8,11,14-eicosatetraenoic acid. 2011 Carcinogenesis pmid:21393477
Trofimiuk E and Braszko JJ Long-term administration of cod liver oil ameliorates cognitive impairment induced by chronic stress in rats. 2011 Lipids pmid:21442272
Chauveau F et al. Brain-targeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact. 2011 Curr Neurovasc Res pmid:21443458
Collins CT et al. Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trial. 2011 Br. J. Nutr. pmid:21443815
Sala-Vila A et al. Determinants of the omega-3 index in a Mediterranean population at increased risk for CHD. 2011 Br. J. Nutr. pmid:21450116
Lebold KM et al. Vitamin E deficiency decreases long-chain PUFA in zebrafish (Danio rerio). 2011 J. Nutr. pmid:22013196
Guesnet P and Alessandri JM Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations. 2011 Biochimie pmid:20478353
Sublette ME et al. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. 2011 J Clin Psychiatry pmid:21939614
Serini S et al. Differential anti-cancer effects of purified EPA and DHA and possible mechanisms involved. 2011 Curr. Med. Chem. pmid:21824086
Fagali N and Catalá A Melatonin and structural analogues do not possess antioxidant properties on Fe(2+)-initiated peroxidation of sonicated liposomes made of retinal lipids. 2011 Chem. Phys. Lipids pmid:21827740
Newens KJ et al. DHA-rich fish oil reverses the detrimental effects of saturated fatty acids on postprandial vascular reactivity. 2011 Am. J. Clin. Nutr. pmid:21831993
von Schacky C The Omega-3 Index as a risk factor for cardiovascular diseases. 2011 Prostaglandins Other Lipid Mediat. pmid:21726658
Giltay EJ et al. Effects of n-3 fatty acids on depressive symptoms and dispositional optimism after myocardial infarction. 2011 Am. J. Clin. Nutr. pmid:22030221
Dewell A et al. Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. 2011 J. Nutr. pmid:22031659
Berry KA et al. MALDI imaging MS of phospholipids in the mouse lung. 2011 J. Lipid Res. pmid:21508254
Klebanoff MA et al. Fish consumption, erythrocyte fatty acids, and preterm birth. 2011 Obstet Gynecol pmid:21508745
Altenburg JD et al. A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone. 2011 BMC Cancer pmid:21510869
Mancini I et al. Fatty acid composition of common barbel (Barbus barbus) roe and evaluation of its haemolytic and cytotoxic activities. 2011 Toxicon pmid:21510968
Hadders-Algra M Prenatal and early postnatal supplementation with long-chain polyunsaturated fatty acids: neurodevelopmental considerations. 2011 Am. J. Clin. Nutr. pmid:21525202
Escolano-Margarit MV et al. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. 2011 J. Nutr. pmid:21525247
Rockett BD et al. Membrane raft organization is more sensitive to disruption by (n-3) PUFA than nonraft organization in EL4 and B cells. 2011 J. Nutr. pmid:21525263
De Franceschi G et al. Structural and morphological characterization of aggregated species of α-synuclein induced by docosahexaenoic acid. 2011 J. Biol. Chem. pmid:21527634
Hanada H et al. Induction of apoptosis and lipogenesis in human preadipocyte cell line by n-3 PUFAs. 2011 Cell Biol. Int. pmid:20812919
Milberg P et al. Antiarrhythmic effects of free polyunsaturated fatty acids in an experimental model of LQT2 and LQT3 due to suppression of early afterdepolarizations and reduction of spatial and temporal dispersion of repolarization. 2011 Heart Rhythm pmid:21459164
Nudda A et al. Documentation of fatty acid profiles in lamb meat and lamb-based infant foods. 2011 J. Food Sci. pmid:21535766
Yu YH et al. The function of porcine PPARγ and dietary fish oil effect on the expression of lipid and glucose metabolism related genes. 2011 J. Nutr. Biochem. pmid:20970313
Pomponi MF et al. Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease? 2011 Ageing Res. Rev. pmid:20920611
Wojcicki JM and Heyman MB Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression. 2011 J. Matern. Fetal. Neonatal. Med. pmid:20925595
Kim SH et al. Prospective randomized comparison between omega-3 fatty acid supplements plus simvastatin versus simvastatin alone in Korean patients with mixed dyslipidemia: lipoprotein profiles and heart rate variability. 2011 Eur J Clin Nutr pmid:20877395
Neubronner J et al. Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters. 2011 Eur J Clin Nutr pmid:21063431
Sasaki K et al. Total synthesis and bioactivities of two proposed structures of maresin. 2011 Chem Asian J pmid:21254430
Huang L et al. Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. 2011 Pain pmid:21255928
van der Pols JC et al. Serum omega-3 and omega-6 fatty acids and cutaneous p53 expression in an Australian population. 2011 Cancer Epidemiol. Biomarkers Prev. pmid:21217086
Belin RJ et al. Fish intake and the risk of incident heart failure: the Women's Health Initiative. 2011 Circ Heart Fail pmid:21610249
Poudel-Tandukar K et al. Long chain n-3 fatty acids intake, fish consumption and suicide in a cohort of Japanese men and women--the Japan Public Health Center-based (JPHC) prospective study. 2011 J Affect Disord pmid:20692041
Mariee AD and Abd-Ellah MF Protective effect of docosahexaenoic acid against cyclosporine A-induced nephrotoxicity in rats: a possible mechanism of action. 2011 Ren Fail pmid:21219208
Safarinejad MR Effect of omega-3 polyunsaturated fatty acid supplementation on semen profile and enzymatic anti-oxidant capacity of seminal plasma in infertile men with idiopathic oligoasthenoteratospermia: a double-blind, placebo-controlled, randomised study. 2011 Andrologia pmid:21219381
Cotogni P et al. Impact of the omega-3 to omega-6 polyunsaturated fatty acid ratio on cytokine release in human alveolar cells. 2011 JPEN J Parenter Enteral Nutr pmid:21224438
Burrows T et al. Omega-3 index, obesity and insulin resistance in children. 2011 Int J Pediatr Obes pmid:21226540
Zhao Y et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models. 2011 PLoS ONE pmid:21246057
Ueda Y et al. Effect of dietary lipids on longevity and memory in the SAMP8 mice. 2011 J. Nutr. Sci. Vitaminol. pmid:21512289
Cavazos DA et al. Docosahexaenoic acid selectively induces human prostate cancer cell sensitivity to oxidative stress through modulation of NF-κB. 2011 Prostate pmid:21360560
Murphy RA et al. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. 2011 Cancer pmid:21360698
Swenne I et al. Essential fatty acid status in teenage girls with eating disorders and weight loss. 2011 Acta Paediatr. pmid:21362034
Van Dyke TE Proresolving lipid mediators: potential for prevention and treatment of periodontitis. 2011 J. Clin. Periodontol. pmid:21323709
Konkel A and Schunck WH Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. 2011 Biochim. Biophys. Acta pmid:20869469
Harper KN et al. Maternal serum docosahexaenoic acid and schizophrenia spectrum disorders in adult offspring. 2011 Schizophr. Res. pmid:21324652
Grimm MO et al. Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. 2011 J. Biol. Chem. pmid:21324907
Marc I et al. Early docosahexaenoic acid supplementation of mothers during lactation leads to high plasma concentrations in very preterm infants. 2011 J. Nutr. pmid:21169226
Shimshoni JA et al. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder. 2011 Biochim. Biophys. Acta pmid:21184843
Serini S et al. Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 2011 J. Nutr. Biochem. pmid:21185708
Wang RX et al. Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity. 2011 Cardiovasc. Res. pmid:21187320
Riedel M et al. Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of α-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress. 2011 J. Mol. Neurosci. pmid:20725866
Hamazaki K et al. Docosahexaenoic acid is an independent predictor of all-cause mortality in hemodialysis patients. 2011 Am. J. Nephrol. pmid:21196723
Cho JY et al. Oral administration of docosahexaenoic acid attenuates colitis induced by dextran sulfate sodium in mice. 2011 Mol Nutr Food Res pmid:20824662
Pawlik D et al. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. 2011 Pediatrics pmid:21199856